ATE426613T1 - Cc-chemokin-antagonisten - Google Patents
Cc-chemokin-antagonistenInfo
- Publication number
- ATE426613T1 ATE426613T1 AT05850470T AT05850470T ATE426613T1 AT E426613 T1 ATE426613 T1 AT E426613T1 AT 05850470 T AT05850470 T AT 05850470T AT 05850470 T AT05850470 T AT 05850470T AT E426613 T1 ATE426613 T1 AT E426613T1
- Authority
- AT
- Austria
- Prior art keywords
- chemokine antagonists
- chemokine
- saliva
- compounds
- prevention
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 102000001902 CC Chemokines Human genes 0.000 abstract 2
- 108010040471 CC Chemokines Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 241001481696 Rhipicephalus sanguineus Species 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63831204P | 2004-12-21 | 2004-12-21 | |
| EP04106778 | 2004-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE426613T1 true ATE426613T1 (de) | 2009-04-15 |
Family
ID=36297230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05850470T ATE426613T1 (de) | 2004-12-21 | 2005-12-19 | Cc-chemokin-antagonisten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7635576B2 (de) |
| EP (1) | EP1828234B1 (de) |
| AT (1) | ATE426613T1 (de) |
| AU (1) | AU2005318173B2 (de) |
| CA (1) | CA2590446A1 (de) |
| DE (1) | DE602005013572D1 (de) |
| ES (1) | ES2321122T3 (de) |
| IL (1) | IL183925A (de) |
| NO (1) | NO20073773L (de) |
| WO (1) | WO2006067124A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102782148B (zh) * | 2009-08-28 | 2016-04-20 | 瑞泽恩制药公司 | 与多种cc趋化因子结合的抗因子抗体 |
| US11733232B2 (en) | 2017-03-01 | 2023-08-22 | National University Corporation Hokkaido University | Method for producing disease modeling non-human animal, disease modeling non-human animal, and method for screening drug and method for determining risk of disease using the same |
-
2005
- 2005-12-19 WO PCT/EP2005/056929 patent/WO2006067124A2/en active Application Filing
- 2005-12-19 US US11/722,033 patent/US7635576B2/en not_active Expired - Fee Related
- 2005-12-19 DE DE602005013572T patent/DE602005013572D1/de active Active
- 2005-12-19 AT AT05850470T patent/ATE426613T1/de not_active IP Right Cessation
- 2005-12-19 AU AU2005318173A patent/AU2005318173B2/en not_active Ceased
- 2005-12-19 CA CA002590446A patent/CA2590446A1/en not_active Abandoned
- 2005-12-19 ES ES05850470T patent/ES2321122T3/es active Active
- 2005-12-19 EP EP05850470A patent/EP1828234B1/de active Active
-
2007
- 2007-06-14 IL IL183925A patent/IL183925A/en not_active IP Right Cessation
- 2007-07-19 NO NO20073773A patent/NO20073773L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7635576B2 (en) | 2009-12-22 |
| WO2006067124A2 (en) | 2006-06-29 |
| EP1828234B1 (de) | 2009-03-25 |
| EP1828234A2 (de) | 2007-09-05 |
| DE602005013572D1 (de) | 2009-05-07 |
| US20090068173A1 (en) | 2009-03-12 |
| NO20073773L (no) | 2007-09-21 |
| CA2590446A1 (en) | 2006-06-29 |
| AU2005318173B2 (en) | 2011-05-12 |
| IL183925A (en) | 2010-11-30 |
| AU2005318173A1 (en) | 2006-06-29 |
| ES2321122T3 (es) | 2009-06-02 |
| WO2006067124A3 (en) | 2007-04-12 |
| IL183925A0 (en) | 2007-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE478864T1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| DE602006016150D1 (de) | Vorbeugung von krankheiten bei kaiserschnitt-babies | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| DK3530673T3 (da) | Humaniserede anti-beta7-antagonister og anvendelser deraf | |
| NO20065117L (no) | Sammensetning omfattende en JNK inhibitor og syklosporin. | |
| DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
| ATE371451T1 (de) | Duale nk1/nk3 antagonisten zur behandlung von schizophrenie | |
| NO20062694L (no) | Inhibitor av mutant form av KIT | |
| ATE445402T1 (de) | Neue verwendung von pde5-hemmern | |
| WO2005117939A3 (en) | Use of GPCR54 ligands for the treatment of infertility | |
| SE0302304D0 (sv) | Novel compounds | |
| ATE526970T1 (de) | Behandlung von mastitis | |
| IL176327A0 (en) | Cc-chemokine binding proteins, their preparation and their use | |
| EA200702336A1 (ru) | ПРИМЕНЕНИЕ 24-норУДХК | |
| DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
| DE602005014632D1 (de) | Pyrrol- bzw. imidazolamide zur behandlung von obesitas | |
| DK1812797T3 (da) | Sammensætninger og fremgangsmåder til behandling og forebyggelse af hyperproliferative sygdomme | |
| ATE501127T1 (de) | Neue cysteinproteasehemmer und ihre therapeutische anwendung | |
| ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen | |
| ATE426613T1 (de) | Cc-chemokin-antagonisten | |
| DK1503747T3 (da) | Diclofenacbaseret sammensætning til topisk behandling af sygdomme | |
| ATE537184T1 (de) | Neue cxc-chemokin-antagonisten | |
| FR2867026B1 (fr) | Composition phytosanitaire destinee au traitement antifongique des cultures. | |
| DE10394347T5 (de) | Eine synergistische Zusammensetzung zur Behandlung von Hyperlipidämie | |
| DE60322983D1 (de) | Pflanzliche zusammensetzung zur behandlung von gastrointestinalen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |